Health Catalyst, Inc. (HCAT)
- Previous Close
6.03 - Open
5.70 - Bid 5.59 x 200
- Ask 5.62 x 200
- Day's Range
5.55 - 5.95 - 52 Week Range
5.45 - 14.37 - Volume
671,924 - Avg. Volume
611,856 - Market Cap (intraday)
327.953M - Beta (5Y Monthly) 1.29
- PE Ratio (TTM)
-- - EPS (TTM)
-2.09 - Earnings Date May 9, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
11.93
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
www.healthcatalyst.com1,300
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: HCAT
Performance Overview: HCAT
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HCAT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HCAT
Valuation Measures
Market Cap
353.13M
Enterprise Value
284.47M
Trailing P/E
--
Forward P/E
18.83
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.15
Price/Book (mrq)
0.96
Enterprise Value/Revenue
0.96
Enterprise Value/EBITDA
-4.17
Financial Highlights
Profitability and Income Statement
Profit Margin
-39.92%
Return on Assets (ttm)
-7.47%
Return on Equity (ttm)
-29.84%
Revenue (ttm)
295.94M
Net Income Avi to Common (ttm)
-118.15M
Diluted EPS (ttm)
-2.09
Balance Sheet and Cash Flow
Total Cash (mrq)
317.73M
Total Debt/Equity (mrq)
67.88%
Levered Free Cash Flow (ttm)
21.51M
Research Analysis: HCAT
Company Insights: HCAT
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: HCAT
Daily – Vickers Top Buyers & Sellers for 05/15/2023
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 11/15/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 09/09/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 08/22/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.